Selected article for: "active inflammation and lung active inflammation"

Author: Lo Muzio, Lorenzo; Bizzoca, Maria Eleonora; Ravagnan, Giampietro
Title: New intriguing possibility for prevention of coronavirus pneumonitis: Natural purified polyphenols
  • Cord-id: z9c9r3xw
  • Document date: 2020_7_14
  • ID: z9c9r3xw
    Snippet: COVID-19 is an infectious disease characterized by several important systemic problems such as severe pneumonia. One of mechanisms responsible of these systemic problems is the release of pro-inflammatory cytokines, such as interleukin (IL)-1beta and IL-6(Conti et al., 2020). The binding of virus to TRL (Toll Like Receptor) can determine the release of pro-IL-1beta with successive activation and production of active mature IL-1beta, responsible of lung inflammation, fever and fibrosis(Conti et a
    Document: COVID-19 is an infectious disease characterized by several important systemic problems such as severe pneumonia. One of mechanisms responsible of these systemic problems is the release of pro-inflammatory cytokines, such as interleukin (IL)-1beta and IL-6(Conti et al., 2020). The binding of virus to TRL (Toll Like Receptor) can determine the release of pro-IL-1beta with successive activation and production of active mature IL-1beta, responsible of lung inflammation, fever and fibrosis(Conti et al., 2020). The interstitial pneumonia is linked to an over-production of IL-6. Based on this principle, several researchers started the use of an anti-arthritis drug, tocilizumab, for its anti-IL-6 action.

    Search related documents:
    Co phrase search for related documents